- Home
- ATTO vs NBR Comparison
ATTO vs NBR Comparison
Compare ATTO & NBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATTO | NBR |
|---|---|---|
| Founded | 2023 | 1952 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2026 | 2002 |
Fundamental Metrics
Financial Performance| Metric | ATTO | NBR |
|---|---|---|
| Price | $14.12 | $80.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 8 |
| Target Price | $42.20 | ★ $107.38 |
| AVG Volume (30 Days) | ★ 416.7K | 140.1K |
| Earning Date | 09-02-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 177.74 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $5.28 |
| Revenue Next Year | N/A | $9.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.94 | $40.78 |
| 52 Week High | $28.00 | $112.90 |
Technical Indicators
Market Signals| Indicator | ATTO | NBR |
|---|---|---|
| Relative Strength Index (RSI) | 31.42 | 41.53 |
| Support Level | N/A | $75.54 |
| Resistance Level | $18.38 | $84.71 |
| Average True Range (ATR) | 1.18 | 2.87 |
| MACD | -0.23 | 0.00 |
| Stochastic Oscillator | 21.53 | 34.20 |
Price Performance
Historical ComparisonAbout ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
About NBR Nabors Industries Ltd.
Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.